Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.1%

6 terminated/withdrawn out of 194 trials

Success Rate

95.5%

+9.0% vs industry average

Late-Stage Pipeline

20%

39 trials in Phase 3/4

Results Transparency

28%

35 of 127 completed trials have results

Key Signals

25 recruiting35 with results

Enrollment Performance

Analytics

N/A

94(58.4%)

Phase 4

24(14.9%)

Phase 2

18(11.2%)

Phase 3

15(9.3%)

Phase 1

10(6.2%)

161Total

N/A(94)

Phase 4(24)

Phase 2(18)

Phase 3(15)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (194)

Showing 20 of 194 trials

NCT05768763Not ApplicableCompleted

SEARCH SAPPHIRE Phase B

Role: collaborator

NCT06953310Not ApplicableRecruiting

Assessing the Effects of a Multisectoral Agricultural Intervention on the Reproductive and Sexual Health of Adolescent Girls and Young Women

Role: collaborator

NCT07506967Not ApplicableNot Yet Recruiting

Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers

Role: lead

NCT05842122Not ApplicableCompleted

Pharmacy-based PrEP Delivery in Kenya

Role: collaborator

NCT07487077Phase 4Recruiting

Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya

Role: collaborator

NCT05994742Phase 3Active Not Recruiting

An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM

Role: collaborator

NCT06898203Not ApplicableNot Yet Recruiting

Precision Imaging to Evaluate Kaposi Sarcoma

Role: collaborator

NCT05862857Not ApplicableCompleted

The Outreach and Prevention at ALcohol Venues in East Africa Study (OPAL-East Africa- Aim 1)

Role: collaborator

NCT05383755Not ApplicableCompleted

Digital Intervention to Address Stigma Among Pregnant Adolescents Living With HIV

Role: collaborator

NCT06523231Phase 2Completed

Study to Expand Safety and Immunogenicity Data With Shigella Bioconjugate Vaccine (Shigella4V2) in 9-month-old Infants.

Role: collaborator

NCT05117788Active Not Recruiting

Bioneer Q-RFIA Clinical Evaluation

Role: collaborator

NCT06687746Active Not Recruiting

Evaluation of Bili-ruler, a Low-cost, Plastic Icterometer for Community-based Screening of Jaundice in Newborns

Role: collaborator

NCT07387341Not ApplicableNot Yet Recruiting

Long-acting Spatial Emanators / Repellents (LASER)

Role: collaborator

NCT07170748Recruiting

Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)

Role: collaborator

NCT06971367Not ApplicableRecruiting

IBIS Megastudy of Interventions to Encourage HIV Retesting

Role: collaborator

NCT06785103Not ApplicableTerminated

IBIS Megastudy- Pilot

Role: collaborator

NCT06458062Not ApplicableRecruiting

Pocket Colposcopy Using CARE Algorithm

Role: collaborator

NCT04432571Not ApplicableActive Not Recruiting

ADAPT for Adolescents Adolescents

Role: collaborator

NCT04332068Phase 2Completed

Ivermectin Safety in Small Children

Role: collaborator

NCT06519994Phase 2Active Not Recruiting

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

Role: collaborator